Related Experiment Video
Updated: Aug 7, 2026
12:03
Viability Assays for Cells in Culture
Published on: January 20, 2014
Similarities between methamphetamine toxicity and proteasome inhibition
1Department of Human Morphology and Applied Biology, University of Pisa, Pisa, Italy. f.fornai@med.unipi.it
Annals of the New York Academy of Sciences
|November 16, 2004
Summary
Methamphetamine (METH) exposure in mice creates neuronal inclusions similar to those in Parkinson's disease (PD). These inclusions contain alpha-synuclein and ubiquitin, suggesting METH as a valuable PD research model.
Area of Science:
- Neuroscience
- Pathology
- Pharmacology
Background:
- Methamphetamine (METH) is a neurotoxin used to model Parkinson's disease (PD).
- PD is characterized by alpha-synuclein and ubiquitin inclusions in dopaminergic neurons.
- Genetic mutations in the ubiquitin-proteasome (UP) system are linked to inherited PD.
Purpose of the Study:
- To investigate the formation of neuronal inclusions in the nigrostriatal system following METH administration in vivo.
- To characterize the ultrastructure and composition of METH-induced inclusions.
- To determine the role of endogenous dopamine in the formation of these inclusions.
Main Methods:
- Transmission electron microscopy (in vivo and in vitro) to analyze inclusion morphology.
- Immunocytochemistry to identify protein components (ubiquitin, alpha-synuclein, UP-related molecules).
- Pharmacological inhibition of the ubiquitin-proteasome (UP) system using epoxomycin.
- Multifaceted pharmacological approach to assess dopamine's role.
Main Results:
- METH administration induced cytosolic inclusions in the mouse nigrostriatal system.
- These inclusions shared ultrastructural and compositional similarities with Lewy bodies found in PD.
- Inclusions stained positive for ubiquitin, alpha-synuclein, and UP system components.
- Inhibition of the UP system with epoxomycin produced similar inclusions.
- Endogenous dopamine was essential for the formation of these neuronal inclusions.
Conclusions:
- METH administration in mice generates neuronal inclusions resembling those in Parkinson's disease.
- These findings support the use of METH as an experimental model for PD research.
- The ubiquitin-proteasome system and dopamine are critical factors in the pathogenesis of these METH-induced inclusions.
Related Concept Videos
02:18The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
01:13The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
01:20Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
01:17The Proteasome Structure
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...